1. Home
  2. BFRI vs GURE Comparison

BFRI vs GURE Comparison

Compare BFRI & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFRI
  • GURE
  • Stock Information
  • Founded
  • BFRI 1997
  • GURE 2006
  • Country
  • BFRI United States
  • GURE China
  • Employees
  • BFRI N/A
  • GURE N/A
  • Industry
  • BFRI Biotechnology: Pharmaceutical Preparations
  • GURE Major Chemicals
  • Sector
  • BFRI Health Care
  • GURE Industrials
  • Exchange
  • BFRI Nasdaq
  • GURE Nasdaq
  • Market Cap
  • BFRI 8.7M
  • GURE 7.3M
  • IPO Year
  • BFRI 2021
  • GURE 1992
  • Fundamental
  • Price
  • BFRI $0.80
  • GURE $0.71
  • Analyst Decision
  • BFRI Strong Buy
  • GURE
  • Analyst Count
  • BFRI 1
  • GURE 0
  • Target Price
  • BFRI $7.00
  • GURE N/A
  • AVG Volume (30 Days)
  • BFRI 90.7K
  • GURE 40.7K
  • Earning Date
  • BFRI 03-21-2025
  • GURE 11-19-2024
  • Dividend Yield
  • BFRI N/A
  • GURE N/A
  • EPS Growth
  • BFRI N/A
  • GURE N/A
  • EPS
  • BFRI N/A
  • GURE N/A
  • Revenue
  • BFRI $37,321,000.00
  • GURE $12,802,982.00
  • Revenue This Year
  • BFRI $28.62
  • GURE N/A
  • Revenue Next Year
  • BFRI $27.07
  • GURE N/A
  • P/E Ratio
  • BFRI N/A
  • GURE N/A
  • Revenue Growth
  • BFRI 9.54
  • GURE N/A
  • 52 Week Low
  • BFRI $0.65
  • GURE $0.50
  • 52 Week High
  • BFRI $2.43
  • GURE $1.79
  • Technical
  • Relative Strength Index (RSI)
  • BFRI 34.75
  • GURE 49.71
  • Support Level
  • BFRI $0.81
  • GURE $0.65
  • Resistance Level
  • BFRI $0.96
  • GURE $0.78
  • Average True Range (ATR)
  • BFRI 0.08
  • GURE 0.08
  • MACD
  • BFRI -0.01
  • GURE 0.00
  • Stochastic Oscillator
  • BFRI 8.79
  • GURE 53.00

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: